A team built around one conviction: that pediatric health is one of the most important and most compelling places to invest.

John has spent a decade investing in the companies transforming the health of children. He brings 30 years in alternative investments — venture capital, private equity, and hedge funds — to one of the most underleveraged opportunities in life science and healthcare. As a long-serving Trustee of the Charles H. Hood Foundation, he has spent a decade at the intersection of pediatric science, philanthropy, and venture investment. Dartmouth College. Tuck School of Business.

David Cole is the founder of TOO Futures, a children’s health innovation consultancy, and co-founder of Thinking of Oscar, a charity dedicated to bringing the future of healthcare to children. He brings 24 years at IBM — most recently leading Watson Health across Europe, the Middle East, and Africa — to his role at Springhood. A thought leader on AI and pediatric health, he is a digital health expert in residence at Oxford’s Saïd Business School and host of the Not Mini Adults podcast. University of Oxford, MBA.

Paul Kent is the founder of disAbled Life Alliance, committed to accelerating meaningful change for the disability community — with a particular focus on children — a mission rooted in his own experience as one of the first elective participants in a pioneering bilateral amputation procedure. Decades in financial services, including senior leadership in U.S. Equity Sales & Trading at Jefferies. Founder, Idlewood Capital Partners. UCLA.

Bibhash Mukhopadhyay is the founder and CEO of Sapient Biotech Investments and co-founder of Sound Bioventures, a transatlantic biotech venture fund. He previously invested in biotech at New Enterprise Associates and held business development, portfolio management, and corporate strategy roles at AstraZeneca and Johnson & Johnson. His investing career includes financings and IPOs for companies such as Surface Oncology, Ardelyx, and PhaseBio. PhD, Baylor College of Medicine.

Chris Mathia is a two-time exited pediatric medical device CEO. He led Innara Health, maker of the NTrainer system for oral feeding in premature infants, through its acquisition by Cardinal Health, then led TheraB Medical, developer of a wearable phototherapy device for neonatal jaundice, through its acquisition by Natus Sensory. He is an entrepreneur-in-residence at BioHealth Innovation and founder of 2409 Advisors, which provides fractional commercialization leadership to medtech companies. Earlier roles at Cerner and Medline. University of Kansas.